ImmunityBio, Inc 10-Q for FY2021 Q1
ImmunityBio, Inc. (IBRX)
10-Q
2021-05-14
For: 2021-03-31
View Original
Added on
April 10, 2026
About this 10-Q
ImmunityBio, Inc filed this 10-Q on May 14, 2021, covering the quarter ended March 31, 2021 (FY2021 Q1).
Headline figures
Quarter ended March 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $139K
- down 15.8% from $165K a year earlier
- Net loss
- $79.61M
- compared with a net loss of $37.04M a year earlier